The synthesis of biogenic nanoparticles from non-chemical resources has increased the drive toward understanding infection biology. Accordingly, we aimed to address the symbiotic antibiofilm effect of biogenic copper and zinc oxide nanoparticles with antimicrobials against multidrug resistant (MDR) pathogens. The minimum inhibitory concentration (MIC) of copper nanoparticles (CuNPs) and zinc oxide nanoparticles (ZnONPs) at the range from 2 to 128 lg/ml was calculated against Grampositive and Gram-negative pathogenic bacteria using a broth dilution method. Both nanoparticles have prime antibacterial activity compared with standard antibiotics (excluding against P.aeruginosa MTCC 741). A qualitative assessment of biofilm formation and collegial effect was performed using a modified test tube and the microtiter plate-based method by measuring the optical density and time kill of nanoparticles. The results demonstrated efficient antibiofilm activity of CuNPs in its lowest concentration than ZnONPs and antibiotics itself. In addition, significant enhancing antibiofilm effect was also shown by CuNPs in the presence of third generation antibiotics against Gram-negative and Gram-positive bacteria. A scanning electron microscopy (SEM) analysis was used to investigate the effect of the nanoparticles on morphological changes of Staphylococcus aureus. Current data highlights, biogenic CuNPs and ZnONPs could be used as an adjuvant for antibiotics in the treatment of bacterial infections.
Electrochemical water-splitting is rising as the promised pathway to produce pure and green hydrogen. However, the sluggish kinetics of the oxygen evolution reaction (OER) and slow reaction rate of hydrogen...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.